Skip to main content

View Diary: Medicare: Shifting Costs to Patients (61 comments)

Comment Preferences

  •  Recombinant insulin is expensive (1+ / 0-)
    Recommended by:
    Mr Robert

    I think the cost runs from about $4,000 to $9,000/year in the USA on average for an insulin user.

    •  That sounds about right (0+ / 0-)

      It used to be possible to purchase drugs like Humalog and Lantus from Canada for about 1/3rd the price, but keeping it cool during shipping is impossible because it has to go through US customs and that takes over a week. Even if it's in a cooler it gets too warm after a few days and the pharmacies were having to give too many refunds so they raised the prices to match those here in the US.

      I recently paid $365 for 15 ml of Humalog (5 x 3ml) at Walmart. That's the cash price w/o insurance. I used to get it free of charge directly from Lilly through their Patient Assistance Program. But, once I turned 65 I was no longer eligible.

      I use very little Humalog so that will last me about four months, but many diabetics would burn through that amount in a month. So the cost just for fast acting insulin would come to $4,272 per year.

      The cost for long acting (24 hour basal) insulin would be about the same. So the yearly cost would be over $8,000.

      When I looked at Medicare Part-D policies I found that the premium + deductable + copay was so high that it didn't save me any money as compared to paying cash so I'm going w/o a Part-D policy at least for now.

      The only trouble with retirement is...I never get a day off!

      by Mr Robert on Mon Jul 29, 2013 at 11:01:54 AM PDT

      [ Parent ]

Subscribe or Donate to support Daily Kos.

Click here for the mobile view of the site